83 related articles for article (PubMed ID: 668505)
1. [Changes of unspecific immune parameters (CH50E, C3, C4, C3A, lysozyme, CRP at the end of 2-year use of a synthetic sex steroid drug].
Stelzner A; Klinger G; Süsse I; Kittlick M; Süss J
Dtsch Gesundheitsw; 1978; 33(29):1381-5. PubMed ID: 668505
[No Abstract] [Full Text] [Related]
2. [The clinical value of unspecific humoral immune parameters. Attempt at an immunogram. II. Quantitative determination of CH50E, CB50E, C3, C4 and lysozyme and measurement of indirect phagocytosis rate in the serum of patients with chronic pyelonephritis].
Stelzner A; Stein G; Kittlick M
Z Gesamte Inn Med; 1979 Mar; 34(6):153-9. PubMed ID: 382656
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
Arnold M; Tóth I; Faredin I
Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
[No Abstract] [Full Text] [Related]
4. [Impact of synthetic sexual steroids on blood volume (author's transl)].
Klinger G; Stoll W; Zinner G; Krause G; Carol W
Zentralbl Gynakol; 1982; 104(6):343-8. PubMed ID: 7046293
[TBL] [Abstract][Full Text] [Related]
5. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
Zellner P; Klinger G
Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
[No Abstract] [Full Text] [Related]
6. Transcortin as an indicator of estrogenic potency in oral contraceptives.
Carol W; Börner A; Klinger G; Greinke C
Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
[TBL] [Abstract][Full Text] [Related]
7. [A new 2-step combination preparation for hormonal contraception].
James A
Schweiz Rundsch Med Prax; 1982 Dec; 71(51):1990-3. PubMed ID: 7163134
[No Abstract] [Full Text] [Related]
8. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
9. [Endocrinologic and pharmacologic-toxicologic findings with ethinyl-estradiol sulfonate. 8th communication. Complement and lysozyme in the serum of beagles after 6 months application of ethinylestradiol sulfonate].
Stelzner A; Klein Y; Klein U; Klinger G; Oettel M; Chemnitius KH
Endokrinologie; 1976 Jul; 67(3):301-6. PubMed ID: 976204
[TBL] [Abstract][Full Text] [Related]
10. Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives.
Tedder RS; Nelson M; Eisen V
Br J Exp Pathol; 1975 Oct; 56(5):389-95. PubMed ID: 1212421
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of the use of a new tri-phasic pill].
Giobbe C; Piacentino R; Marchino GL; Zaccheo F; Cellura A; Ferrara L; Mazza O; Caccuri D; Condello V; Grio R
Minerva Ginecol; 1990 Nov; 42(11):463-6. PubMed ID: 2080034
[TBL] [Abstract][Full Text] [Related]
12. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
Dernellis J; Panaretou M
Am J Cardiol; 2006 Jan; 97(2):245-8. PubMed ID: 16442371
[TBL] [Abstract][Full Text] [Related]
13. Uterine response to prostaglandin e2 under oral contraceptives.
Toppozada M; Khowessah M; Shaala S; Said S; Osman M
Contraception; 1976 Jun; 13(6):749-61. PubMed ID: 1277847
[No Abstract] [Full Text] [Related]
14. Blood platelet biochemistry in women receiving steroid contraceptives.
Briggs M
Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
[No Abstract] [Full Text] [Related]
15. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest].
Figoureux J; Onghena G; Schlikker E; Wattiez M; Schlösser W; Vercautere E; William P
Munch Med Wochenschr; 1967 Dec; 109(48):2555-8. PubMed ID: 5631905
[No Abstract] [Full Text] [Related]
16. [Effect of Deposiston on hormone secretion of the renin-aldosterone system, the adrenal cortex and the pituitary - ovary system].
Branczeisz J; Hubl W; Freymann E; Sarembe B
Z Arztl Fortbild (Jena); 1983; 77(3):109-11. PubMed ID: 6344451
[No Abstract] [Full Text] [Related]
17. Clinical and laboratory experience with a modified low dosage sequential oral contraceptive.
Wamsteker EF
Int J Fertil; 1968; 13(4):436-43. PubMed ID: 5700403
[No Abstract] [Full Text] [Related]
18. [Effect of the hormonal estrogen-progestagen preparation Loveston on gland cells of the endometrium in the rat].
Sliwa W; Ciszek V; Grzybek H; Tomczok J; Panz B; Cmiel G; Ciszek M
Ginekol Pol; 1988 Nov; 59(11):661-7. PubMed ID: 3253153
[No Abstract] [Full Text] [Related]
19. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraceptives on vitamin B6 nutriture of young women.
Vir SC; Love AH
Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
